Oct 6, 2021 | Comparative Effectiveness, Cost Savings, MedBen Rx, Rx Costs, Savings
By using comparative effectiveness to deliver the best drug outcomes, MedBen Rx clients save between 10-30% on pharmacy costs. Would you like to find out how much you could save? MedBen Rx offers a no-cost, no-obligation analysis of the savings potential from adding...
Oct 6, 2021 | Case Studies, Claims, Claims Management, Cost Savings, Forensic claims analysis, Savings
A MedBen Client received two large dollar claims for Mast Cell Activation Disease, both of which were flagged. In addition to occurrences of unbundling, following physician review it was determined that the length of hospital stay exceeded standards for medical...
Aug 24, 2021 | Alternative Reimbursement Strategies, Cost Savings, Direct-to-Employer Contracting, Reference-Based Pricing, Spending
MedBen clients spend an average of 23.5% less when using direct-to-employer contracting (DTE) or reference-based pricing (RBP) plans. But how do our alternative reimbursement strategies affect spending for specific types of patient care? For inpatient care, MedBen...
Aug 10, 2021 | Cost Savings, MedBen WellLiving, Savings, Trend
Last year, MedBen’s WellLiving block had 8.8% less claim costs compared to those who didn’t utilize WellLiving. But that number doesn’t tell the whole story. Over the past five years, the cost gap between WellLiving and non-WellLiving members has continued to...
Aug 9, 2021 | Brand Name Drugs, Comparative Effectiveness, Cost Savings, Generic Drugs, MedBen Rx, Rx Costs, Savings
Generic doesn’t always mean cheap. As this list recently compiled by GoodRx demonstrates, the monthly cost of some popular generic drugs can actually rival or exceed well-known brand medications. MedBen Rx comparative effectiveness ensures that members are using...
Jul 12, 2021 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Transparency
Lack of disclosure is a common theme for many pharmacy benefit managers (PBMs), be it with employers or state governments. From Benefits Pro: “At least a half-dozen states and the District of Columbia are investigating pharmacy benefit managers, The Wall Street...
